{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T19:28:44Z","timestamp":1779218924062,"version":"3.51.4"},"reference-count":95,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019725","name":"Deanship of Scientific Research, Prince Sattam bin Abdulaziz University","doi-asserted-by":"publisher","award":["PSAU\/2025\/R\/1446"],"award-info":[{"award-number":["PSAU\/2025\/R\/1446"]}],"id":[{"id":"10.13039\/100019725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022230","name":"Deanship of Scientific Research, Princess Nourah Bint Abdulrahman University","doi-asserted-by":"publisher","award":["PNURSP2025R736"],"award-info":[{"award-number":["PNURSP2025R736"]}],"id":[{"id":"10.13039\/501100022230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Axitinib is a second-generation tyrosine kinase inhibitor that works by selectively inhibiting vascular endothelial growth factor receptors (VEGFR-1, VEGFR-2, VEGFR-3). Through this mechanism of action, axitinib blocks angiogenesis, tumor growth and metastases and therefor it shows significant promise as a chemotherapeutic agent for various types of cancer. Nevertheless, the clinical efficacy of this substance is hindered by its restricted solubility in water and inadequate stability. To address these challenges, we developed spanlastics with polyethylene glycol (PEG) to improve the efficacy and stability of axitinib against breast and ovarian tumor malignancies in a targeted manner. Moreover, the study conducts a thorough examination of the interactions between the ligand Axitinib alone or after coating with PEG and a diverse array of protein types in breast (Dopamine, VEGFR) and ovarian cancer (EGFR, BCL-xL). The fabrication of axitinib- spanlastics was achieved through a thin-film hydration method. The evaluation of the impact of formulation factors on the features of nanovesicles was conducted using the I- optimal design. Subsequently, the optimum formulation was calculated. The optimal formulation was coated with polyethylene glycol (axitinib-PEG-spanlastics). An <jats:italic>in vitro<\/jats:italic> assessment was computed to evaluate the efficiency of the optimized axitinib-PEG-spanlastics against the MCF-7 breast cancer cell line and the OV-2774 ovarian cancer cell line. The optimized axitinib-PEG-spanlastics formulation exhibited a diameter of 563.42\u2009\u00b1\u20098.63\u2009nm, accompanied by a zeta potential of \u221246.44\u2009\u00b1\u20090.09 mV. The formulation demonstrated an 84.32\u2009\u00b1\u20093.64% entrapment percent and a cumulative release of 73.58\u2009\u00b1\u20093.37% during a 4-hour period. The results obtained from the WST-1 assay showed a significant decrease in the percentage of cell survival, reaching 50% at a concentration of 0.68 \u00b5M for the PEG-spanlastics. In contrast, the axitinib free drug suspension exhibited 50% cell survival at a concentration of 1.1 \u00b5M in the breast cancer (MCF-7) cell line. In MCF-7 cells, the percentage of apoptotic cells generated by axitinib-PEG-spanlastics compared to the free drug suspension was 70.76\u2009\u00b1\u20094.971% vs. 32.6\u2009\u00b1\u20091.803%, while in OV-2774 cells, it was 43.55\u2009\u00b1\u20094.243% vs. 24.44\u2009\u00b1\u20094.950%. These results propose that Axitinib-PEG-spanlastics have the potential to be a successful nanoplatform for targeting breast and ovarian cancer and effectively managing tumors.<\/jats:p>","DOI":"10.1371\/journal.pone.0325055","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T17:32:28Z","timestamp":1751391148000},"page":"e0325055","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Fabrication and appraisal of axitinib loaded PEGylated spanlastics against MCF- 7 and OV- 2774 cell lines using molecular docking methods and in-vitro study"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6145-4837","authenticated-orcid":true,"given":"Randa Mohammed","family":"Zaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4398-2510","authenticated-orcid":true,"given":"Basmah Nasser","family":"Aldosari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Layla A.","family":"Alkharashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2027-7951","authenticated-orcid":true,"given":"Alyaa","family":"Alsalhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Obaid","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bodoor Ghanem","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha","family":"Alsunbul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rawan","family":"Bafail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma I.","family":"Abo El-Ela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanan O.","family":"Farouk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"22","key":"pone.0325055.ref001","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.2174\/156802662022200917110555","article-title":"Cancer Estimates in Brazil Reveal Progress for the Most Lethal Malignancies","volume":"20","author":"LLG Ferreira","year":"2020","journal-title":"Curr Top Med Chem"},{"key":"pone.0325055.ref002","doi-asserted-by":"crossref","first-page":"101959","DOI":"10.1016\/j.jddst.2020.101959","article-title":"Docetaxel: An update on its molecular mechanisms, therapeutic trajectory and nanotechnology in the treatment of breast, lung and prostate cancer","volume":"60","author":"M Imran","year":"2020","journal-title":"J Drug Delivery Sci Technol"},{"key":"pone.0325055.ref003","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2019.08.019","article-title":"Paradoxical effects of chemotherapy on tumor relapse and metastasis promotion.","volume-title":"Seminars in cancer biology","author":"C D\u2019Alterio","year":"2020"},{"issue":"4","key":"pone.0325055.ref004","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ophtha.2017.10.010","article-title":"Real-World Vision in Age-Related Macular Degeneration Patients Treated with Single Anti-VEGF Drug Type for 1 Year in the IRIS Registry","volume":"125","author":"P Rao","year":"2018","journal-title":"Ophthalmology"},{"issue":"1","key":"pone.0325055.ref005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/02713683.2012.727520","article-title":"Antiangiogenic effects of axitinib, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, on laser-induced choroidal neovascularization in mice","volume":"38","author":"S Kang","year":"2013","journal-title":"Curr Eye Res"},{"key":"pone.0325055.ref006","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.exer.2016.02.010","article-title":"Axitinib inhibits retinal and choroidal neovascularization in in vitro and in vivo models","volume":"145","author":"A Giddabasappa","year":"2016","journal-title":"Experiment Eye Res"},{"issue":"9","key":"pone.0325055.ref007","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/ceo.13333","article-title":"Topical axitinib is a potent inhibitor of corneal neovascularization","volume":"46","author":"M Lled\u00f3 Riquelme","year":"2018","journal-title":"Clin Exp Ophthalmol"},{"issue":"2","key":"pone.0325055.ref008","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1021\/nn506599f","article-title":"Ocular drug delivery nanowafer with enhanced therapeutic efficacy","volume":"9","author":"X Yuan","year":"2015","journal-title":"ACS Nano"},{"key":"pone.0325055.ref009","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijpharm.2019.01.051","article-title":"Micelle-solubilized axitinib for ocular administration in anti-neovascularization","volume":"560","author":"S Shi","year":"2019","journal-title":"Int J Pharm"},{"key":"pone.0325055.ref010","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.exer.2015.10.016","article-title":"Short-term treatment with VEGF receptor inhibitors induces retinopathy of prematurity-like abnormal vascular growth in neonatal rats","volume":"143","author":"A Nakano","year":"2016","journal-title":"Exp Eye Res"},{"issue":"7","key":"pone.0325055.ref011","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1167\/tvst.10.7.19","article-title":"Evaluation of Long-Lasting Potential of Suprachoroidal Axitinib Suspension Via Ocular and Systemic Disposition in Rabbits","volume":"10","author":"VS Kansara","year":"2021","journal-title":"Transl Vis Sci Technol"},{"issue":"10","key":"pone.0325055.ref012","article-title":"The association of alternate VEGF ligands with resistance to anti-VEGF therapy in metastatic colorectal cancer","volume":"8","author":"CH Lieu","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"pone.0325055.ref013","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.oret.2017.04.004","article-title":"Bevacizumab Injection in Patients with Neovascular Age-Related Macular Degeneration Increases Angiogenic Biomarkers","volume":"2","author":"T Cabral","year":"2018","journal-title":"Ophthalmol Retina"},{"issue":"6","key":"pone.0325055.ref014","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s40259-021-00499-2","article-title":"Anti-VEGF and other novel therapies for neovascular age-related macular degeneration: an update","volume":"35","author":"M Parravano","year":"2021","journal-title":"BioDrugs"},{"key":"pone.0325055.ref015","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","article-title":"Pharmacokinetic aspects of retinal drug delivery","volume":"57","author":"EM Del Amo","year":"2017","journal-title":"Prog Retin Eye Res"},{"key":"pone.0325055.ref016","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.actbio.2016.05.012","article-title":"PEGylated lipid bilayer-supported mesoporous silica nanoparticle composite for synergistic co-delivery of axitinib and celastrol in multi-targeted cancer therapy","volume":"39","author":"JY Choi","year":"2016","journal-title":"Acta Biomater"},{"issue":"3","key":"pone.0325055.ref017","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1039\/C4TB01442A","article-title":"Systemic delivery of axitinib with nanohybrid liposomal nanoparticles inhibits hypoxic tumor growth","volume":"3","author":"JY Choi","year":"2015","journal-title":"J Mater Chem B"},{"issue":"12","key":"pone.0325055.ref018","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1158\/1078-0432.CCR-04-2280","article-title":"Down-regulated xanthine oxidoreductase is a feature of aggressive breast cancer","volume":"11","author":"N Linder","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"6","key":"pone.0325055.ref019","doi-asserted-by":"crossref","first-page":"7301","DOI":"10.1096\/fj.201802415RR","article-title":"The emerging role of xanthine oxidase inhibition for suppression of breast cancer cell migration and metastasis associated with hypercholesterolemia","volume":"33","author":"S-H Oh","year":"2019","journal-title":"FASEB J"},{"key":"pone.0325055.ref020","doi-asserted-by":"crossref","first-page":"154894","DOI":"10.1016\/j.prp.2023.154894","article-title":"Anti-breast cancer potential of a new xanthine derivative: In silico, antiproliferative, selectivity, VEGFR-2 inhibition, apoptosis induction and migration inhibition studies","volume":"251","author":"IH Eissa","year":"2023","journal-title":"Pathol Res Pract"},{"issue":"2","key":"pone.0325055.ref021","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ygyno.2011.10.026","article-title":"Decreased xanthine oxidoreductase (XOR) is associated with a worse prognosis in patients with serous ovarian carcinoma","volume":"124","author":"N Linder","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"4","key":"pone.0325055.ref022","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3390\/nu15040931","article-title":"Purine Intake and All-Cause Mortality in Ovarian Cancer: Results from a Prospective Cohort Study","volume":"15","author":"Z Du","year":"2023","journal-title":"Nutrients"},{"key":"pone.0325055.ref023","doi-asserted-by":"crossref","unstructured":"Mai Z, et al. Gut-derived metabolite 3-methylxanthine enhances cisplatin-induced apoptosis via dopamine receptor D1 in a mouse model of ovarian cancer. 2023.","DOI":"10.21203\/rs.3.rs-3501298\/v1"},{"key":"pone.0325055.ref024","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2014.04.015","article-title":"Nano-niosomes as nanoscale drug delivery systems: an illustrated review","volume":"185","author":"S Moghassemi","year":"2014","journal-title":"J Control Release"},{"key":"pone.0325055.ref025","doi-asserted-by":"crossref","first-page":"102725","DOI":"10.1016\/j.jddst.2021.102725","article-title":"Spanlastics as an efficient delivery system for the enhancement of thymoquinone anticancer efficacy: Fabrication and cytotoxic studies against breast cancer cell lines","volume":"65","author":"E Alaaeldin","year":"2021","journal-title":"J Drug Delivery Sci Technol"},{"key":"pone.0325055.ref026","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2147\/IJN.S347187","article-title":"Nanoparticles in Combating Neuronal Dysregulated Signaling Pathways: Recent Approaches to the Nanoformulations of Phytochemicals and Synthetic Drugs Against Neurodegenerative Diseases","volume":"17","author":"S Fakhri","year":"2022","journal-title":"Int J Nanomedicine"},{"issue":"5","key":"pone.0325055.ref027","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s002800050837","article-title":"Camptothecin delivery systems: enhanced efficacy and tumor accumulation of camptothecin following its conjugation to polyethylene glycol via a glycine linker","volume":"42","author":"CD Conover","year":"1998","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"pone.0325055.ref028","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1021\/bc040241m","article-title":"PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity","volume":"16","author":"FM Veronese","year":"2005","journal-title":"Bioconjug Chem"},{"issue":"25","key":"pone.0325055.ref029","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.1016\/j.biomaterials.2014.04.108","article-title":"A PEG-Fmoc conjugate as a nanocarrier for paclitaxel","volume":"35","author":"P Zhang","year":"2014","journal-title":"Biomaterials"},{"issue":"3","key":"pone.0325055.ref030","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.xphs.2021.11.007","article-title":"Harnessing of Doxylamine Succinate\/Pyridoxine Hydrochloride-Dual Laden Bilosomes as a Novel Combinatorial Nanoparadigm for Intranasal Delivery: In Vitro Optimization and In Vivo Pharmacokinetic Appraisal","volume":"111","author":"HF Salem","year":"2022","journal-title":"J Pharm Sci"},{"key":"pone.0325055.ref031","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijpharm.2017.03.005","article-title":"Enhanced non invasive trans-tympanic delivery of ciprofloxacin through encapsulation into nano-spanlastic vesicles: Fabrication, in-vitro characterization, and comparative ex-vivo permeation studies","volume":"522","author":"AM Al-Mahallawi","year":"2017","journal-title":"Int J Pharm"},{"issue":"1","key":"pone.0325055.ref032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2005.02.021","article-title":"Effect of cholesterol and ethanol on dermal delivery from DPPC liposomes","volume":"298","author":"J Lopez-Pinto","year":"2005","journal-title":"Int J Pharm"},{"key":"pone.0325055.ref033","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.colsurfb.2016.01.014","article-title":"Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: Mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability","volume":"141","author":"W Zeng","year":"2016","journal-title":"Colloids Surf B Biointerfaces"},{"key":"pone.0325055.ref034","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ijbiomac.2016.01.013","article-title":"Chitosan gel-embedded moxifloxacin niosomes: An efficient antimicrobial hybrid system for burn infection","volume":"85","author":"S Sohrabi","year":"2016","journal-title":"Int J Biol Macromol"},{"key":"pone.0325055.ref035","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.2147\/DDDT.S120613","article-title":"Transbuccal delivery of betahistine dihydrochloride from mucoadhesive tablets with a unidirectional drug flow: in vitro, ex vivo and in vivo evaluation","author":"MA El-Nabarawi","year":"2016","journal-title":"Drug Design Develop Therapy"},{"issue":"4","key":"pone.0325055.ref036","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1208\/s12249-008-9171-4","article-title":"Solubility enhancement of lovastatin by modified locust bean gum using solid dispersion techniques","volume":"9","author":"M Patel","year":"2008","journal-title":"AAPS PharmSciTech"},{"key":"pone.0325055.ref037","doi-asserted-by":"crossref","first-page":"105295","DOI":"10.1016\/j.jddst.2023.105295","article-title":"Development, optimization, and assessment of losartan nano-bilosomes to mitigate diabetes-induced microvascular complications in Sprague Dawley rats","volume":"92","author":"M Qushawy","year":"2024","journal-title":"J Drug Delivery Sci Technol"},{"issue":"4","key":"pone.0325055.ref038","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/adt.2019.920","article-title":"Axitinib-Loaded Poly(Lactic-Co-Glycolic Acid) Nanoparticles for Age-Related Macular Degeneration: Formulation Development and In Vitro Characterization","volume":"17","author":"P Narvekar","year":"2019","journal-title":"Assay Drug Dev Technol"},{"issue":"2","key":"pone.0325055.ref039","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems","volume":"10","author":"M Danaei","year":"2018","journal-title":"Pharmaceutics"},{"key":"pone.0325055.ref040","first-page":"100225","article-title":"Repurposing celecoxib for colorectal cancer targeting via pH-triggered ultra-elastic nanovesicles: Pronounced efficacy through up-regulation of Wnt\/\u03b2-catenin pathway in DMH-induced tumorigenesis","volume":"7","author":"SF El Menshawe","year":"2023","journal-title":"Int J Pharm X"},{"issue":"8","key":"pone.0325055.ref041","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3390\/ph15080940","article-title":"Central Composite Optimization of Glycerosomes for the Enhanced Oral Bioavailability and Brain Delivery of Quetiapine Fumarate","volume":"15","author":"RM Zaki","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"pone.0325055.ref042","first-page":"100208","article-title":"Box Behnken optimization of cubosomes for enhancing the anticancer activity of metformin: Design, characterization, and in-vitro cell proliferation assay on MDA-MB-231 breast and LOVO colon cancer cell lines","volume":"6","author":"RM Zaki","year":"2023","journal-title":"Int J Pharm X"},{"issue":"1","key":"pone.0325055.ref043","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1080\/10717544.2019.1686087","article-title":"Transdermal delivery of fluvastatin sodium via tailored spanlastic nanovesicles: mitigated Freund\u2019s adjuvant-induced rheumatoid arthritis in rats through suppressing p38 MAPK signaling pathway","volume":"26","author":"SF El Menshawe","year":"2019","journal-title":"Drug Deliv"},{"issue":"9","key":"pone.0325055.ref044","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.2174\/1567201815666180619105419","article-title":"Implementing central composite design for developing transdermal diacerein-loaded niosomes: ex vivo permeation and in vivo deposition","volume":"15","author":"DE Aziz","year":"2018","journal-title":"Current Drug Delivery"},{"issue":"3","key":"pone.0325055.ref045","first-page":"318","article-title":"Role of nanoparticles in drug delivery system: a comprehensive review","volume":"9","author":"C Karuppusamy","year":"2017","journal-title":"J Pharm Sci Res"},{"issue":"1","key":"pone.0325055.ref046","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1080\/10717544.2018.1477858","article-title":"Novel in situ gelling vaginal sponges of sildenafil citrate-based cubosomes for uterine targeting","volume":"25","author":"HM Aboud","year":"2018","journal-title":"Drug Deliv"},{"issue":"5","key":"pone.0325055.ref047","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3390\/gels9050400","article-title":"Numerical Optimization of Prednisolone-Tacrolimus Loaded Ultraflexible Transethosomes for Transdermal Delivery Enhancement; Box-Behnken Design, Evaluation, Optimization, and Pharmacokinetic Study","volume":"9","author":"MM Alfadhel","year":"2023","journal-title":"Gels"},{"key":"pone.0325055.ref048","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.2147\/IJN.S196771","article-title":"Use of transethosomes for enhancing the transdermal delivery of olmesartan medoxomil: in vitro, ex vivo, and in vivo evaluation","volume":"14","author":"R Albash","year":"2019","journal-title":"Int J Nanomedicine"},{"issue":"7","key":"pone.0325055.ref049","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1002\/jps.21612","article-title":"Preparation and characterization of negatively charged poly(lactic-co-glycolic acid) microspheres","volume":"98","author":"Q Xu","year":"2009","journal-title":"J Pharm Sci"},{"key":"pone.0325055.ref050","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0927-7765(03)00080-8","article-title":"Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol","volume":"30","author":"A Manosroi","year":"2003","journal-title":"Colloids Surfaces B"},{"issue":"12","key":"pone.0325055.ref051","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.3390\/pharmaceutics14122627","article-title":"Spanlastics as a Potential Platform for Enhancing the Brain Delivery of Flibanserin: In Vitro Response-Surface Optimization and In Vivo Pharmacokinetics Assessment","volume":"14","author":"WS Alharbi","year":"2022","journal-title":"Pharmaceutics"},{"issue":"19","key":"pone.0325055.ref052","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1016\/j.biomaterials.2012.03.046","article-title":"Vitamin E TPGS as a molecular biomaterial for drug delivery","volume":"33","author":"Z Zhang","year":"2012","journal-title":"Biomaterials"},{"key":"pone.0325055.ref053","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijpharm.2010.06.034","article-title":"Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery","volume":"397","author":"GM El Zaafarany","year":"2010","journal-title":"Int J Pharm"},{"issue":"3","key":"pone.0325055.ref054","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1021\/la062042s","article-title":"Colloidal stabilization of nanoparticles in concentrated suspensions","volume":"23","author":"AR Studart","year":"2007","journal-title":"Langmuir"},{"issue":"5","key":"pone.0325055.ref055","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.xphs.2018.01.005","article-title":"Surfactant Effects on Lipid-Based Vesicles Properties","volume":"107","author":"R Bnyan","year":"2018","journal-title":"J Pharm Sci"},{"issue":"1","key":"pone.0325055.ref056","article-title":"Phospholipid-stabilized nanoparticles of cyclosporine A by rapid expansion from supercritical to aqueous solution","volume":"5","author":"TJ Young","year":"2004","journal-title":"AAPS PharmSciTech"},{"key":"pone.0325055.ref057","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.2147\/IJN.S423251","article-title":"Curcumin Transferosome-Loaded Thermosensitive Intranasal in situ Gel as Prospective Antiviral Therapy for SARS-Cov-2","volume":"18","author":"NE Eleraky","year":"2023","journal-title":"Int J Nanomedicine"},{"issue":"8","key":"pone.0325055.ref058","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1016\/j.xphs.2021.04.020","article-title":"Novel chitosan-coated niosomal formulation for improved management of bacterial conjunctivitis: a highly permeable and efficient ocular nanocarrier for azithromycin","volume":"110","author":"HM Eid","year":"2021","journal-title":"J Pharm Sci"},{"key":"pone.0325055.ref059","doi-asserted-by":"crossref","first-page":"6249","DOI":"10.2147\/IJN.S319348","article-title":"Implementing Spanlastics for Improving the Ocular Delivery of Clotrimazole: In vitro Characterization, Ex vivo Permeability, Microbiological Assessment and In vivo Safety Study","volume":"16","author":"MA Abdelbari","year":"2021","journal-title":"Int J Nanomedicine"},{"issue":"2","key":"pone.0325055.ref060","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/jcis.1999.6663","article-title":"Zeta Potential of Nanobubbles Generated by Ultrasonication in Aqueous Alkyl Polyglycoside Solutions","volume":"223","author":"J Kim","year":"2000","journal-title":"J Colloid Interface Sci"},{"issue":"1","key":"pone.0325055.ref061","first-page":"261","article-title":"Effects of functional group of non-ionic surfactants on the stability of emulsion","volume":"19","author":"N Ibrahim","year":"2015","journal-title":"Malaysian J Anal Sci"},{"issue":"11","key":"pone.0325055.ref062","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.3390\/pharmaceutics14112521","article-title":"Wound healing efficacy of rosuvastatin transethosomal gel, I optimal optimization, histological and in vivo evaluation","volume":"14","author":"RM Zaki","year":"2022","journal-title":"Pharmaceutics"},{"key":"pone.0325055.ref063","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.2147\/IJN.S238709","article-title":"Mitigation of Rheumatic Arthritis in a Rat Model via Transdermal Delivery of Dapoxetine HCl Amalgamated as a Nanoplatform: In vitro and in vivo Assessment","volume":"15","author":"HF Salem","year":"2020","journal-title":"Int J Nanomedicine"},{"key":"pone.0325055.ref064","volume-title":"Liposomes and The Use of Zeta Potential Measurements to Study Sterically Stabilized Liposomes","author":"M Panalytical","year":"2005"},{"issue":"28","key":"pone.0325055.ref065","doi-asserted-by":"crossref","first-page":"7080","DOI":"10.1021\/acs.jpcb.8b03742","article-title":"Molecular Insight into Drug-Loading Capacity of PEG-PLGA Nanoparticles for Itraconazole","volume":"122","author":"N Wilkosz","year":"2018","journal-title":"J Phys Chem B"},{"key":"pone.0325055.ref066","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.biopha.2017.07.110","article-title":"Poly (d, l-lactide-co-glycolide) nanoparticles for sustained release of tacrolimus in rabbit eyes","volume":"94","author":"MA Kalam","year":"2017","journal-title":"Biomed Pharmacotherapy"},{"key":"pone.0325055.ref067","first-page":"100228","article-title":"Formulation, optimization and evaluation of ocular gel containing nebivolol Hcl-loaded ultradeformable spanlastics nanovesicles: In vitro and in vivo studies","volume":"7","author":"M Yasser","year":"2024","journal-title":"Int J Pharmaceutics"},{"issue":"32","key":"pone.0325055.ref068","doi-asserted-by":"crossref","first-page":"5504","DOI":"10.1039\/D1CE00620G","article-title":"Cocrystallization of axitinib with carboxylic acids: preparation, crystal structures and dissolution behavior","volume":"23","author":"BY Ren","year":"2021","journal-title":"CrystEngComm"},{"issue":"9","key":"pone.0325055.ref069","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1021\/acsnano.5b03876","article-title":"Impact of Surface Polyethylene Glycol (PEG) Density on Biodegradable Nanoparticle Transport in Mucus ex Vivo and Distribution in Vivo","volume":"9","author":"Q Xu","year":"2015","journal-title":"ACS Nano"},{"issue":"1","key":"pone.0325055.ref070","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11095-015-1767-2","article-title":"Development of a Sustained Release Solid Dispersion Using Swellable Polymer by Melting Method","volume":"33","author":"TN-G Nguyen","year":"2016","journal-title":"Pharm Res"},{"issue":"11","key":"pone.0325055.ref071","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e02919","article-title":"Co-encapsulation of thymoquinone with docetaxel enhances the encapsulation efficiency into PEGylated liposomes and the chemosensitivity of MCF7 breast cancer cells to docetaxel","volume":"5","author":"F Odeh","year":"2019","journal-title":"Heliyon"},{"key":"pone.0325055.ref072","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.eurpolymj.2018.04.020","article-title":"In vitro and in vivo biocompatibility study of folate-lysine-PEG-PCL as nanocarrier for targeted breast cancer drug delivery","volume":"103","author":"M Zamani","year":"2018","journal-title":"Europe Polymer J"},{"issue":"1","key":"pone.0325055.ref073","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3390\/ph14010068","article-title":"Formulation and Optimization of Nanospanlastics for Improving the Bioavailability of Green Tea Epigallocatechin Gallate","volume":"14","author":"EA Mazyed","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"pone.0325055.ref074","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/IJN.S289828","article-title":"Topical Nano-Vesicular Spanlastics of Celecoxib: Enhanced Anti-Inflammatory Effect and Down-Regulation of TNF-\u03b1, NF-\u043aB and COX-2 in Complete Freund\u2019s Adjuvant-Induced Arthritis Model in Rats","volume":"16","author":"E Alaaeldin","year":"2021","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"pone.0325055.ref075","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/10717544.2021.1886377","article-title":"Topical delivery of l-ascorbic acid spanlastics for stability enhancement and treatment of UVB induced damaged skin","volume":"28","author":"M Elhabak","year":"2021","journal-title":"Drug Deliv"},{"key":"pone.0325055.ref076","doi-asserted-by":"crossref","first-page":"101751","DOI":"10.1016\/j.mtcomm.2020.101751","article-title":"Anticancer effect of green tea extract (GTE)-loaded pH-responsive niosome coated with PEG against different cell lines","volume":"26","author":"M Baranei","year":"2021","journal-title":"Mater Today Commun"},{"issue":"14","key":"pone.0325055.ref077","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1080\/00914037.2020.1776282","article-title":"Pegylated multifunctional pH-responsive targeted polymeric micelles for ovarian cancer therapy: synthesis, characterization and pharmacokinetic study","volume":"70","author":"M Kazemi","year":"2021","journal-title":"Int J Polymeric Mater Polymeric Biomater"},{"key":"pone.0325055.ref078","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jphotobiol.2016.06.049","article-title":"Binding of an anticancer drug, axitinib to human serum albumin: Fluorescence quenching and molecular docking study","volume":"162","author":"S Tayyab","year":"2016","journal-title":"J Photochem Photobiol B"},{"issue":"19","key":"pone.0325055.ref079","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/am504566v","article-title":"Injectable dopamine-modified poly(ethylene glycol) nanocomposite hydrogel with enhanced adhesive property and bioactivity","volume":"6","author":"Y Liu","year":"2014","journal-title":"ACS Appl Mater Interfaces"},{"issue":"2","key":"pone.0325055.ref080","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bcp.2015.03.013","article-title":"Dopamine enhances the response of sunitinib in the treatment of drug-resistant breast cancer: Involvement of eradicating cancer stem-like cells","volume":"95","author":"S Wang","year":"2015","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"pone.0325055.ref081","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41401-018-0006-x","article-title":"Antitumor effect of axitinib combined with dopamine and PK-PD modeling in the treatment of human breast cancer xenograft","volume":"40","author":"Y-H Ma","year":"2019","journal-title":"Acta Pharmacol Sin"},{"issue":"8","key":"pone.0325055.ref082","doi-asserted-by":"crossref","first-page":"744","DOI":"10.2174\/1389203721666200511093733","article-title":"Melatonin Modulates Lactation by Regulating Prolactin Secretion Via Tuberoinfundibular Dopaminergic Neurons in the Hypothalamus- Pituitary System","volume":"21","author":"H Li","year":"2020","journal-title":"Curr Protein Pept Sci"},{"key":"pone.0325055.ref083","doi-asserted-by":"crossref","first-page":"111084","DOI":"10.1016\/j.mce.2020.111084","article-title":"Three lactation-related hormones: Regulation of hypothalamus-pituitary axis and function on lactation","volume":"520","author":"Y Ni","year":"2021","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"pone.0325055.ref084","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.3168\/jds.2019-17330","article-title":"Effects of milking frequency and domperidone injections on milk production and prolactin signaling in the mammary gland of dairy cows","volume":"103","author":"I Toledo","year":"2020","journal-title":"J Dairy Sci"},{"issue":"2","key":"pone.0325055.ref085","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1534-5807(04)00022-X","article-title":"Serotonin regulates mammary gland development via an autocrine-paracrine loop","volume":"6","author":"M Matsuda","year":"2004","journal-title":"Dev Cell"},{"key":"pone.0325055.ref086","doi-asserted-by":"crossref","first-page":"45686","DOI":"10.1038\/srep45686","article-title":"Inhibitory Effects of Dopamine Receptor D1 Agonist on Mammary Tumor and Bone Metastasis","volume":"7","author":"K Minami","year":"2017","journal-title":"Sci Rep"},{"key":"pone.0325055.ref087","doi-asserted-by":"crossref","first-page":"172499","DOI":"10.1016\/j.ejphar.2019.172499","article-title":"Dopamine D1 receptor agonists inhibit lung metastasis of breast cancer reducing cancer stemness","volume":"859","author":"L Yang","year":"2019","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"pone.0325055.ref088","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ygyno.2008.02.030","article-title":"Implications of EGFR inhibition in ovarian cancer cell proliferation","volume":"109","author":"SL Bull Phelps","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"18","key":"pone.0325055.ref089","doi-asserted-by":"crossref","first-page":"5268","DOI":"10.1158\/1078-0432.CCR-05-1554","article-title":"The epidermal growth factor receptor pathway: a model for targeted therapy","volume":"12","author":"M Scaltriti","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"7","key":"pone.0325055.ref090","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","article-title":"Cell signaling by receptor tyrosine kinases","volume":"141","author":"MA Lemmon","year":"2010","journal-title":"Cell"},{"issue":"2","key":"pone.0325055.ref091","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/35052073","article-title":"Untangling the ErbB signalling network","volume":"2","author":"Y Yarden","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"pone.0325055.ref092","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMct0807960","article-title":"Treatment of non\u2013small-cell lung cancer with erlotinib or gefitinib","volume":"364","author":"VD Cataldo","year":"2011","journal-title":"New England J Med"},{"key":"pone.0325055.ref093","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/01635581.2013.785004","article-title":"Chemopreventive and anti-cancer efficacy of silibinin against growth and progression of lung cancer","volume":"65","author":"S Mateen","year":"2013","journal-title":"Nutr Cancer"},{"issue":"12","key":"pone.0325055.ref094","doi-asserted-by":"crossref","first-page":"111826","DOI":"10.1016\/j.celrep.2022.111826","article-title":"BCL-xL inhibition potentiates cancer therapies by redirecting the outcome of p53 activation from senescence to apoptosis","volume":"41","author":"V Bharti","year":"2022","journal-title":"Cell Rep"},{"issue":"1","key":"pone.0325055.ref095","doi-asserted-by":"crossref","first-page":"14177","DOI":"10.1038\/s41598-024-64696-z","article-title":"Low BCL-xL expression in triple-negative breast cancer cells favors chemotherapy efficacy, and this effect is limited by cancer-associated fibroblasts","volume":"14","author":"L Nocquet","year":"2024","journal-title":"Sci Rep"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0325055","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T17:32:51Z","timestamp":1751391171000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0325055"}},"subtitle":[],"editor":[{"given":"Yusuf Ahmed","family":"Haggag","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":95,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0325055","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]}}}